Aug 31, 2022
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Aug. 31, 2022-- 2seventy bio, Inc . (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, announced today that members of the management team will participate in the following upcoming investor conferences: 17th Annual Citi BioPharma Conference , “Cell
Aug 03, 2022
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Aug. 3, 2022-- 2seventy bio, Inc . (Nasdaq: TSVT) announced today that members of the management team will participate in the following upcoming investor conferences: 2022 Wedbush PacGrow Healthcare Conference , “A View to a Kill(er Cell) – Part 1” panel on